Related Experiment Video

Updated: Feb 5, 2026

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
07:31

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

18.2K

The cutting edge of metastatic melanoma therapy

Antonia Digklia1, Olivier Michielin1

  • 1Department of Oncology, Centre Hospitalier Universitaire Vaudois, Bugnon 46, 1011 Lausanne, Switzerland.

Melanoma Management
|September 8, 2018
PubMed

Insights

Recent advances in melanoma treatment include targeted therapies for BRAF/NRAS mutations and immune checkpoint inhibitors, significantly improving patient prognosis. Identifying predictive biomarkers is crucial for optimizing these advanced melanoma treatment strategies.

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Melanoma treatment has significantly advanced in the past decade.
  • Discovery of oncogenic driver mutations (e.g., BRAF, NRAS) has transformed prognosis for stage IV melanoma.
  • Targeted therapies and immune checkpoint inhibitors show high response rates and survival benefits.

Purpose of the Study:

  • To review recent developments in melanoma treatment.
  • To highlight the role of targeted therapies and immune checkpoint inhibitors.
  • To emphasize the need for predictive biomarkers in optimizing therapeutic strategies.

Main Methods:

  • Review of preclinical and clinical studies on melanoma treatment.
  • Analysis of genomic data for identification of new driver mutations.
  • Evaluation of immune checkpoint inhibitors' efficacy and development pace.

Main Results:

  • Targeted inhibitors of BRAF/NRAS mutations demonstrate significant survival benefits over conventional chemotherapy.
  • Genomic analyses have identified novel potentially targetable driver mutations in melanoma.
  • Immune checkpoint inhibitors offer the potential for long-term clinical benefit in melanoma patients.

Conclusions:

  • The therapeutic landscape for melanoma has been revolutionized by targeted therapies and immunotherapy.
  • Further research is needed to identify predictive biomarkers for patient selection.
  • Optimizing treatment strategies requires integrating genomic insights and biomarker development for personalized melanoma care.
Keywords:
BRAFclinical studiesimmunotherapymelanomatherapy

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K

Related Concept Videos

Cut-off Frequency of BJT01:17

Cut-off Frequency of BJT

Cut-off frequencies in Bipolar Junction Transistors (BJTs) mark the transition between the signal's pass band and stop band, influencing their performance in amplifying or attenuating frequencies. These frequencies are crucial for designing BJTs to meet specific operational requirements in electronic circuits.
Alpha Cut-Off Frequency: Pertinent to the common-base configuration, the alpha cut-off frequency defines the upper-frequency limit at which the current gain, alpha, remains stable. As...
1.4K
Brick Cutting Techniques01:08

Brick Cutting Techniques

Brick-cutting techniques involve various tools and methods to shape bricks for construction. A mason's hammer with a chisel-pointed end is used for basic shaping through sharp, precise strikes. For more complex shapes requiring higher precision, a power saw with a water-cooled diamond blade is used.
Cut bricks are categorized by size. Bricks cut to half their original length are called half-bats, while those cut to three-fourths their length are known as three-fourth bats.
Special types of...
660
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
725